Stay updated on DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.

Latest updates to the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added, and older notices including the funding-lapse message and 'Revision: v3.4.1' were removed. These are minor maintenance updates that do not affect study content or user actions on the page.SummaryDifference0.4%

- Check21 days agoChange DetectedNew top banner informs visitors about a lapse in government funding and NIH Clinical Center status with links for updates. The page revision is labeled v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary and makes minor metadata label updates (for example, Last Update Submitted that Met QC Criteria and No FEAR Act Data) along with a new revision tag (Revision: v3.4.0) replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study Locations section was updated to reflect new and reorganized sites (Connecticut, Michigan, Texas, Quebec, and A Coruna), with the page revision updated to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedAdded note that PubMed publications are automatically filled in from PubMed and may not all relate to the study, and updated the Revision to v3.3.2. Replaced the previous text stating publications come from PubMed and were auto-generated with v3.2.0.SummaryDifference0.1%

Stay in the know with updates to DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.